COVID-19 Saliva-based Screening Market 2022-2031

New Study Reports "COVID-19 Saliva-based Screening Market 2022 Global Analysis By Key Regions, Production, Consumption, Revenue, Applications, Growth and Forecasts 2031" has been Added on PersistenceMarketResearch.

Report Details:

The COVID-19 Saliva-based Screening Market is expected to grow on a vigorous note shortly. Though telemedicine has turned out to be an easily accessible service, proper amalgamation with therapy decisions is of utmost importance. At-home lab tests are a good by-product of telehealth. Remote monitoring and diagnosis are cost-effective. It also saves on downtime. So, saving on time and investing in convenience would be one of the trends of the healthcare vertical in the years to come.

As per Persistence Market Research’s latest industry analysis, the global COVID-19 saliva-based screening market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a declining CAGR of -3% over the forecast period of 2021 to 2031.

COVID-19 saliva-based screening is attaining traction in the existing situation, as it is patient-friendly, easy to use, and has a shorter test-to-result timeline. COVID-19 saliva-based screening plays a dynamic role in screening asymptomatic persons, thus sustaining market growth. This is mainly owing to numerous advantages offered by saliva-based tests, growing product approvals by FDA, and a shift toward point-of-care testing.

With the onset of the COVID-19 pandemic, several key players have entered the screening market. Advertising and expansion strategies are also playing an important role in generating market revenue. Furthermore, manufacturers are investing extensively in research & development activities to develop novel techniques that can allow rapid testing and accurate results.

Key Players:

The report has profiled some of the important players prevalent in the global like – Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc, Arcis Biotechnology Limited, GeneProof, Abacus ALS, Chai Inc., Kolplast Group, Lucence Health INc, Vitagene, Therma Bright Inc, ACON Laboratories, Inc, TODA PHARMA, Norgen Biotek Corp., Assure Tech. (Hangzhou) Co., Ltd, Beijing Hotgen Biotech Co., Ltd, Nantong Diagnos Biotechnology Co., Ltd, NeuMoDx Molecular, Inc., KYODO INTERNATIONAL INC., Canvax, Zymo Research Corporation., Salimetrics, NEST Scientific USA, Miraclean Technology Co. Ltd, Mawi DNA Technologies, Cell Projects Ltd. and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the COVID-19 Saliva-based Screening Market.

Request for Free Sample Report of “COVID-19 Saliva-based Screening” Market @ https://www.persistencemarketresearch.com/samples/32712                                                                                                                                                                  

Product launches, approvals, and acquisitions & mergers are rampant in this market space:

Abbott launched ID NOW, a molecular POCT for detecting novel coronavirus (COVID-19), authorized by the U.S. FDA-issued Emergency Use Authorization (EUA). It is small, lightweight (6.6 pounds) and portable (size of a small toaster), and uses molecular technology that delivers positive results in as little as five minutes and negative results in 13 min.
In April 2021, Chembio Diagnostics, Inc. announced the launch of an FDA emergency use authorization-approved, in-licensed rapid POCT for COVID-19/Flu A&B test, for use in decentralized and traditional testing settings.
Thermo Fisher Scientific acquired Mesa Biotech, a developer of hand-held test devices for COVID-19 detection. Mesa received approximately US$ 450 Mn in cash and became eligible for an additional US$ 100 Mn based on the completion of certain pre-discussed milestones. This acquisition enabled Thermo Fisher Scientific to accelerate the availability of reliable and accurate advanced molecular diagnostics at POCT.
Key Takeaways from Market Study

Based on product, saliva-based detection kits are leading with over 83% market share.
By technology, RT-qPCR technology holds around 49% market value share, globally, primarily due to increasing focus on rapid testing and growing research activities.
COVID-19 diagnostics is estimated to dominate the market by application. This segment accounted for approximately 63% share of the market, primarily due to rising prevalence of Covid-19 and increasing demand for COVID-19 diagnostics
Diagnostic laboratories dominate the market among the end users with a market share of 27%.
By region, Europe is set to dominate the global market with a value share of around 36%.
North America is slated to be the second-largest leading market with a value share of 34% through 2031.
“Increasing adoption of COVID-19 saliva-based screening, rising ageing population susceptible to COVID-19, and continuous guidance from governments to support the response effect of the pandemic are estimated to boost market growth over the coming years," says an analyst of Persistence Market Research.

Request For Customization@ https://www.persistencemarketresearch.com/request-customization/32712              

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Araia, South Africa etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Key Questions Answered in the COVID-19 Saliva-based Screening Market Report

How is the COVID-19 Saliva-based Screening Market expected to grow over the projected period?

What direction is the COVID-19 Saliva-based Screening Market expected to take in terms of volume and value during the forecast period?

What is the impact of macroeconomic factors on the COVID-19 Saliva-based Screening Market in future?

What are the key market drivers in the COVID-19 Saliva-based Screening Market?

What are significant opportunities and improvement areas for COVID-19 Saliva-based Screening Market manufacturers?

What are the key developments and trends taking over the COVID-19 Saliva-based Screening Market?

Which are the emerging countries that are expected to create significant growth opportunities in the COVID-19 Saliva-based Screening Market?  

If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.

Click Here to Buy this Report@ https://www.persistencemarketresearch.com/checkout/32712                                                                                                                                                                                                                                                                                                                                                             

Continued...

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against reputed organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Media Contact:

Persistence Market Research

305 Broadway,7th Floor New York City, NY 10007 United States

Call +1-646-568-7751

Call +1 800-961-0353

[email protected]